Home
About
FAQ
History (22)
IMP3: a diagnostic and prognostic biomarker in malignant melanoma.
S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.
Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction.
Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.
IMP-3 expression in melanocytic lesions.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IMP-3 expression in melanocytic lesions.
Yu L, Xu H, Wasco MJ, Bourne PA, Ma L. IMP-3 expression in melanocytic lesions. J Cutan Pathol. 2010 Mar; 37(3):316-22.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Diagnosis, Differential
Female
Humans
Immunohistochemistry
Male
Melanoma
Middle Aged
Nevus
RNA-Binding Proteins
Skin Neoplasms
authors with profiles
Haodong Xu MD, PhD